Armata Pharmaceuticals
ARMP
ARMP
25 hedge funds and large institutions have $4.17M invested in Armata Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.02% more ownership
Funds ownership: 3.55% → 3.57% (+0.02%)
Holders
25
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$175K | |
| 2 | +$69.2K | |
| 3 | +$3.13K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$936 |
| 5 |
TVAMP
Tennessee Valley Asset Management Partners
Knoxville,
Tennessee
|
+$904 |
Top Sellers
| 1 | -$162K | |
| 2 | -$34.4K | |
| 3 | -$12.7K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$7.16K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$6.74K |